17,104 Shares in Centene Corporation $CNC Bought by Valeo Financial Advisors LLC

Valeo Financial Advisors LLC purchased a new stake in Centene Corporation (NYSE:CNC) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 17,104 shares of the company’s stock, valued at approximately $610,000.

Other institutional investors have also made changes to their positions in the company. Mowery & Schoenfeld Wealth Management LLC bought a new position in Centene during the third quarter worth about $27,000. WPG Advisers LLC lifted its position in shares of Centene by 44.5% during the 3rd quarter. WPG Advisers LLC now owns 915 shares of the company’s stock worth $33,000 after buying an additional 282 shares during the period. Bogart Wealth LLC grew its position in Centene by 11,011.1% in the third quarter. Bogart Wealth LLC now owns 1,000 shares of the company’s stock valued at $36,000 after acquiring an additional 991 shares during the period. Financial Network Wealth Advisors LLC raised its stake in Centene by 54.9% during the third quarter. Financial Network Wealth Advisors LLC now owns 1,100 shares of the company’s stock worth $39,000 after acquiring an additional 390 shares in the last quarter. Finally, Quent Capital LLC bought a new position in shares of Centene during the third quarter valued at $45,000. 93.63% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

CNC has been the subject of a number of recent analyst reports. Robert W. Baird increased their target price on shares of Centene from $28.00 to $36.00 and gave the stock a “neutral” rating in a research report on Thursday, December 11th. Mizuho set a $47.00 price objective on shares of Centene in a report on Friday, January 9th. Truist Financial boosted their target price on Centene from $45.00 to $47.00 and gave the stock a “buy” rating in a report on Monday, January 5th. UBS Group set a $42.00 price target on Centene and gave the company a “neutral” rating in a report on Thursday, October 30th. Finally, Sanford C. Bernstein restated an “outperform” rating and set a $59.00 target price on shares of Centene in a report on Tuesday, January 6th. Three investment analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $40.81.

Centene Stock Down 0.7%

Shares of CNC opened at $43.31 on Friday. The business’s fifty day moving average price is $41.86 and its two-hundred day moving average price is $35.47. The firm has a market capitalization of $21.29 billion, a price-to-earnings ratio of -4.00, a PEG ratio of 1.01 and a beta of 0.48. Centene Corporation has a 52 week low of $25.08 and a 52 week high of $66.81. The company has a debt-to-equity ratio of 0.83, a quick ratio of 1.08 and a current ratio of 1.08.

Centene (NYSE:CNC) last issued its quarterly earnings results on Wednesday, October 29th. The company reported $0.50 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.21) by $0.71. The business had revenue of $49.69 billion for the quarter, compared to analyst estimates of $47.50 billion. Centene had a positive return on equity of 7.82% and a negative net margin of 2.85%.The firm’s revenue for the quarter was up 18.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.62 earnings per share. On average, analysts predict that Centene Corporation will post 6.86 earnings per share for the current year.

Centene Company Profile

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.